Study guide
8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents
Certified Nuclear Medicine Technologist CNMT
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current CNMT Exam Facts 1.2 How to Use This Guide
2 Radiation Physics Fundamentals
2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles
3 Biological Effects & ALARA
3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring
4 NRC & Regulatory Compliance
4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records
5 Generators & Kit Preparation
5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control
6 Tc-99m Diagnostic Agents
6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells
7 Non-Tc Diagnostic & PET Agents
7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents
8 Therapeutics, Adjuncts & Administration
8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents
9 Non-Imaging Instrumentation
9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment
10 Imaging Systems & Quality Control
10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization
11 Pulmonary, Bone, Oncology & Infection Imaging
11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures
12 Renal, Endocrine & Hematopoietic Imaging
12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique
13 Cardiovascular Procedures
13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing
14 GI, CNS, Therapy & Hybrid CT Procedures
14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency
15 Patient Care & Clinical Workflow
15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis
8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents
Key Takeaways Explain This Topic AI
Lidocaine is an amide local anesthetic injected intradermally or subcutaneously for painful access; EMLA® cream (lidocaine 2.5% plus prilocaine 2.5%) is applied under an occlusive dressing about 60 minutes before venipuncture and is a pediatric mainstay.
H2 receptor antagonists—cimetidine, famotidine, or ranitidine—are given before Meckel diverticulum scintigraphy to inhibit parietal-cell secretion so pertechnetate is retained in ectopic gastric mucosa instead of washing into the lumen.
Stable iodine blockade with Lugol's solution, SSKI, or potassium perchlorate protects the thyroid before radioiodinated agents such as I-123 MIBG and I-123 ioflupane; blockade starts before the dose and continues per the package insert.
Atropine is an anticholinergic given in small incremental IV doses during dobutamine stress when the heart-rate target is not reached, and for symptomatic bradycardia—not as a vasodilator reversal agent.
A fatty oral supplement such as Boost® or Ensure® stimulates endogenous cholecystokinin to contract the gallbladder, but standardized sincalide infusion remains the reference method when a numeric gallbladder ejection fraction is required.
Last updated: August 2026
8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents
Quick Answer: Lidocaine / EMLA® = comfort at the needle (EMLA needs ~60 minutes under occlusion ). H2 blockers = retain pertechnetate in ectopic gastric mucosa for Meckel's . Lugol's / SSKI / perchlorate = thyroid blockade before radioiodinated agents. Atropine = rescue chronotropy during dobutamine stress. Boost®/Ensure® = fatty-meal gallbladder contraction. Contrast media = hybrid CT, with allergy, renal, and iodine-load consequences.
Section 8.2 covered the stress, renal, biliary, brain, and therapy-support adjuncts. The blueprint also names a second group that shows up in real workflow constantly and on the exam through prep and timing items.
Local Anesthesia: Lidocaine and EMLA® Cream
Agent Form and use Timing Cautions
Lidocaine Amide local anesthetic, commonly 1%–2% injected intradermally/subcutaneously before difficult IV access, arterial lines for Y-90 mapping support, or physician-performed intrathecal punctures Onset within minutes ; duration roughly 1–2 hours Confirm allergy history (amide vs ester agents); use preservative-free product when the route requires it; aspirate to avoid intravascular injection; systemic toxicity presents as perioral tingling, tinnitus, then arrhythmia or seizure
EMLA® cream Eutectic mixture of lidocaine 2.5% + prilocaine 2.5% , applied topically under an occlusive dressing Apply about 60 minutes before venipuncture (longer for deeper procedures) The prilocaine component carries a methemoglobinemia risk in infants and in patients on other oxidizing drugs; respect maximum application area and dwell time by weight
Practical scheduling matters: an EMLA site must be prepped an hour ahead, so pediatric bone scans and renograms are ordered with cream applied on the floor before transport. Technologists apply and remove topical anesthetics under institutional policy; injected lidocaine follows the site's credentialing rules.
Acid Blockade for Meckel Diverticulum Scintigraphy
Tc-99m pertechnetate is secreted by gastric mucin-producing cells , so ectopic gastric mucosa in a Meckel diverticulum concentrates it. Secretion into the bowel lumen then washes activity away and blurs the focus.
Premedication Effect
Cimetidine, famotidine, or ranitidine (H2 antagonists) Inhibit parietal-cell acid secretion , which reduces washout of pertechnetate from the mucosa and raises target-to-background — the standard, well-tolerated choice
Pentagastrin Stimulates uptake but is less favored because of side effects
Glucagon Slows peristalsis (about 50 µg/kg IV , max 1 mg, in sterile water—not saline); avoided in diabetic patients and used selectively
H2 blockade is typically started the day before or the morning of the study per protocol. Trap: giving a perchlorate blocking agent instead—perchlorate blocks the trapping mechanism and would defeat the study.
Stable Iodine Thyroid Blockade
Free radioiodide from radioiodinated agents concentrates in the thyroid. Blockade saturates or blocks the sodium-iodide symporter (NIS) .
- Agent Notes
- Lugol's solution Strong iodine solution; dose in drops per protocol
- SSKI (saturated solution of potassium iodide) Equivalent blockade; often easier to dose
- Potassium perchlorate Competitive NIS blocker; the alternative when iodine allergy or sensitivity is a concern
When it applies: I-123 MIBG (AdreView®) , I-123 ioflupane (DaTscan®) , and other radioiodinated products per their inserts. Blockade begins before the radiopharmaceutical (commonly about an hour ahead) and may continue for a defined period afterward. Never give stable iodine to a patient scheduled for a thyroid uptake, radioiodine survey, or I-131 therapy —it floods the iodine pool and ruins the study.
Atropine
Atropine is an anticholinergic that blocks vagal tone and increases heart rate.
Use Practice
Dobutamine stress Small incremental IV doses when the target heart rate is not achieved at the top infusion stage
Symptomatic bradycardia Emergency use per ACLS and standing orders
Cautions Narrow-angle glaucoma, significant urinary retention/prostatism, tachyarrhythmias; expect dry mouth, blurred vision, and urinary hesitancy
Trap: atropine supports dobutamine; it does not reverse it. Excess dobutamine effect is managed by stopping the infusion and, if needed, a short-acting beta blocker . Aminophylline reverses vasodilator stress, not either of these.
Oral Fat Challenge: Boost® and Ensure®
A fatty oral supplement triggers endogenous cholecystokinin release and gallbladder contraction.
Scenario Role
Prolonged fasting or TPN before hepatobiliary imaging Contract a distended, sludge-filled gallbladder so tracer can enter
Gallbladder emptying assessment when standardized sincalide is unavailable Acceptable alternative, but reference values differ
Quantitative gallbladder ejection fraction Standardized sincalide infusion is the reference method —do not substitute a milkshake and report a numeric GBEF against sincalide norms
Also remember the subdiaphragmatic activity use case: a fatty snack or milk can accelerate hepatobiliary clearance before repeat myocardial perfusion imaging when liver and bowel activity crowd the inferior wall.
Contrast Media (Oral and IV)
Hybrid imaging brings CT contrast into the nuclear medicine department.
Consideration Technologist action
Allergy history Screen for prior contrast reaction; premedication with corticosteroid plus antihistamine is a physician order with a defined lead time
- Renal function Check creatinine/eGFR per policy before iodinated IV contrast
- Metformin Follow institutional policy on holding and restarting after IV contrast
Iodine load Iodinated contrast blocks thyroid radioiodine uptake for weeks to months —never give it shortly before a thyroid uptake, radioiodine survey, or planned I-131 therapy
Extravasation Recognize swelling, pain, and firmness; stop the injection, elevate, and follow the reaction protocol
- Oral contrast Bowel opacification for diagnostic CT; may cause attenuation-correction artifacts on PET/CT
- Matching Table
- Prompt Adjunct
- Child terrified of the needle for a bone scan EMLA® applied about an hour ahead
- Meckel scan ordered for painless rectal bleeding H2 blocker premedication
- I-123 MIBG for suspected pheochromocytoma Lugol's/SSKI or perchlorate blockade
- Dobutamine at 40 µg/kg/min, heart rate still 62 Atropine increments per protocol
- Hepatobiliary study in a patient on TPN for two weeks Sincalide pretreatment or a fatty meal per protocol
- PET/CT with diagnostic-quality CT ordered IV/oral contrast with allergy and renal screening
Bottom line: these agents change comfort, secretion, uptake, or heart rate—never the radionuclide. Learn the timing relative to the tracer and the one screening question that stops the study.